Microbot Medical Inc.
MBOT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $7 | $6 | $8 | $6 |
| G&A Expenses | $5 | $4 | $6 | $5 |
| SG&A Expenses | $5 | $4 | $6 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $12 | $10 | $13 | $11 |
| Operating Income | -$12 | -$10 | -$13 | -$11 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$1 | $0 | $0 |
| Pre-Tax Income | -$11 | -$11 | -$13 | -$11 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$11 | -$13 | -$11 |
| % Margin | – | – | – | – |
| EPS | -0.73 | -1.05 | -1.81 | -1.59 |
| % Growth | 30.5% | 42% | -13.8% | – |
| EPS Diluted | -0.73 | -1.05 | -1.81 | -1.59 |
| Weighted Avg Shares Out | 16 | 10 | 7 | 7 |
| Weighted Avg Shares Out Dil | 16 | 10 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$11 | -$11 | -$13 | -$11 |
| % Margin | – | – | – | – |